Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
about
Vitamin K for improved anticoagulation control in patients receiving warfarinDirect thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillationDirect thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with non-valvular atrial fibrillationVitamin K for improved anticoagulation control in patients receiving warfarinSelf-monitoring and self-management of oral anticoagulationOral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksOral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksAntiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacksOral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacksAnticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatranSelf-monitoring and self-management of oral anticoagulationPharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectivesFrequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillationDental extraction in patients on warfarin treatmentProthrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trialAnticoagulation in atrial fibrillationStroke and the "stroke belt" in dialysis: contribution of patient characteristics to ischemic stroke rate and its geographic variationImpact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage riskPsychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin.Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective studyPersonalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.Erratum: utilization of anticoagulation therapy in medicare patients with nonvalvular atrial fibrillationGenetic risk factors for major bleeding in patients treated with warfarin in a community setting.Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic reviewRisk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.Feasibility Study of a Mobile Health Intervention for Older Adults on Oral Anticoagulation Therapy.Incremental prognostic information from kidney function in patients with new onset coronary heart disease.Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.Pharmacological management of atrial fibrillation: one, none, one hundred thousand.Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial.Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathwaysSafe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-makingEffects of neferine on the pharmacokinetics of amiodarone in rats.Prothrombin complex concentrates: an update.Attitudes and preferences on the use of mobile health technology and health games for self-management: interviews with older adults on anticoagulation therapyDoes aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.
P2860
Q24194649-DE5AF6A1-5EAB-446B-AEC7-B976B349D561Q24197843-F20E0BDA-EB89-43ED-B441-9842F69FAA55Q24202488-E72DED4C-0368-454F-B872-2F0994C579A9Q24202915-A6800470-56EA-4418-9B0A-ACB74CB4CF52Q24235798-1F148EC3-B7B9-4534-A25E-81B512B79F78Q24244298-3EFC88A2-037D-4E41-9E0E-EF53A9C9D89CQ24244742-151DA735-6232-4B8C-A39A-039A04122953Q24245569-381BE21E-4B61-44FF-B6BF-79AC28B02299Q24246644-5FEDA5D1-D7E4-4BDF-ABF6-C57D405B144EQ24807132-805B389D-7137-436E-A7A6-1E516EE4236CQ26471166-216BABE8-6F52-4775-B422-EEA5DD4ABBAAQ26773091-E25E8C9E-F1CD-44B9-AEFD-402DFC21FF79Q28183704-F69C6766-A78D-488A-BBCD-341AFDE7DFC4Q28246951-F489C28B-D2EE-4BEF-ADE7-796A75B99D23Q28265484-99A87E8A-FA84-4185-B6B5-954C132095EFQ28315636-0766CB08-6251-499D-B349-0E12CD53FBCEQ28391692-53348FAA-8EB6-4F72-974B-F956956AC4D5Q30371014-39AC3B3F-F160-48F2-9DA9-22BB94DEEF25Q30570918-6F779B42-B658-4BDE-9239-B46AFC0FF02BQ33232061-44AB0823-F446-4099-88B8-42C475A38F48Q33572430-917EEDF3-00EC-4A28-A299-CB15CD62B1DFQ33643975-0BF98BB7-9605-4E06-A917-D0D27D91964AQ33692552-2587BE44-BDCC-4B76-8C94-2802EB9B0015Q33714864-BAF5AB8F-B2C2-404B-BC24-B1B3B188B7C1Q33792352-2758B970-19D8-44C2-9D93-BEDA1075D345Q33795571-86BE2B87-C0A8-43CC-B433-063407DA7023Q33821854-DC3092EE-5706-4E0B-825A-E93B84450D3AQ33840468-2616F26B-6971-416B-9B5D-8E285AF0948FQ33870476-D66DC7FD-9716-491E-ABD5-E465E9C1D303Q33891646-38361250-A198-4217-824B-B54C70DDE0F4Q33902193-EFFAA4C5-4199-4A0A-A667-228E55534215Q33911000-C8DD1F6B-879D-4E8A-A175-9BC1EEADEA87Q33920598-A09E7399-E69D-4A01-9B44-7AB6D6C28D43Q33923776-E46B525E-D229-4B2A-986C-6CD0194216E7Q33949571-9C98E5CF-9075-4486-88EF-71EA335D8972Q33950584-F2738807-47B8-420A-BFA6-0C78A0665085Q34003474-E8C575ED-A71F-46B6-BC8A-9186768A74CBQ34015470-B307AFCE-F551-4358-B912-B36D06B268FCQ34082043-001F2862-516A-48F7-97D2-6DF4179895A6Q34200483-A59E7207-B59F-4A22-AD63-708AB4752A83
P2860
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Anticoagulation therapy for st ...... nslate into clinical practice?
@ast
Anticoagulation therapy for st ...... nslate into clinical practice?
@en
Anticoagulation therapy for st ...... nslate into clinical practice?
@nl
type
label
Anticoagulation therapy for st ...... nslate into clinical practice?
@ast
Anticoagulation therapy for st ...... nslate into clinical practice?
@en
Anticoagulation therapy for st ...... nslate into clinical practice?
@nl
prefLabel
Anticoagulation therapy for st ...... nslate into clinical practice?
@ast
Anticoagulation therapy for st ...... nslate into clinical practice?
@en
Anticoagulation therapy for st ...... nslate into clinical practice?
@nl
P2093
P3181
P356
P1476
Anticoagulation therapy for st ...... nslate into clinical practice?
@en
P2093
Angela M Capra
Daniel E Singer
Joe V Selby
Kathleen A Phillips
Lori E Henault
Nancy G Jensvold
Yuchiao Chang
P304
P3181
P356
10.1001/JAMA.290.20.2685
P407
P50
P577
2003-11-26T00:00:00Z